Business Description
Baijin Life Science Holdings Ltd
NAICS : 339910
SIC : 3915
ISIN : KYG0130B1014
Total Employee Number:
79Compare
Compare
Traded in other countries / regions
01466.Hong KongMNNGF.USA IPO Date
2015-02-19Description
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.67 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | 11.33 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.99 | |||||
Beneish M-Score | -0.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.3 | |||||
3-Year EPS without NRI Growth Rate | 33.6 | |||||
3-Year Book Growth Rate | 18.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 43.75 | |||||
14-Day RSI | 55.21 | |||||
6-1 Month Momentum % | 25 | |||||
12-1 Month Momentum % | -6.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.21 | |||||
Quick Ratio | 2.88 | |||||
Cash Ratio | 1.09 | |||||
Days Inventory | 267.6 | |||||
Days Sales Outstanding | 71.79 | |||||
Days Payable | 34.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32 | |||||
Shareholder Yield % | -8.35 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.1 | |||||
Operating Margin % | -4.06 | |||||
Net Margin % | 6.75 | |||||
EBITDA Margin % | 6.29 | |||||
FCF Margin % | -17.24 | |||||
OCF Margin % | -15.43 | |||||
ROE % | 6.61 | |||||
ROA % | 3 | |||||
ROIC % | -2.61 | |||||
3-Year ROIIC % | 6.12 | |||||
ROC (Joel Greenblatt) % | 1.69 | |||||
ROCE % | 0.58 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 84 | |||||
PE Ratio without NRI | 84 | |||||
PS Ratio | 5.79 | |||||
PB Ratio | 4.62 | |||||
Price-to-Tangible-Book | 7.5 | |||||
EV-to-EBIT | 676.47 | |||||
EV-to-EBITDA | 109.83 | |||||
EV-to-Revenue | 6.91 | |||||
EV-to-FCF | -40.15 | |||||
Price-to-GF-Value | 1.25 | |||||
Price-to-Median-PS-Value | 1.07 | |||||
Price-to-Graham-Number | 3.75 | |||||
| Price-to-Net-Current-Asset-Value | 7.5 | |||||
Earnings Yield (Greenblatt) % | 0.15 | |||||
FCF Yield % | -2.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MNNGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baijin Life Science Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 15.402 | ||
| EPS (TTM) ($) | 0.001 | ||
| Beta | -4338.5692 | ||
| 3-Year Sharpe Ratio | 0.32 | ||
| 3-Year Sortino Ratio | 0.77 | ||
| Volatility % | 32.15 | ||
| 14-Day RSI | 55.21 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.075 | ||
| 12-1 Month Momentum % | -6.25 | ||
| 52-Week Range ($) | 0.045 - 0.08 | ||
| Shares Outstanding (Mil) | 932.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baijin Life Science Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baijin Life Science Holdings Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2025 | 2024-11-29 | 0.06 (+0.00%) | ||
| General meeting for 2024 | 2024-07-31 | 0.07 (+0.00%) | ||
| 0.1:1 Stock Split | 2020-09-08 | 0.02 (+0.00%) |
Show
Entries
Baijin Life Science Holdings Ltd Frequently Asked Questions
What is Baijin Life Science Holdings Ltd(MNNGF)'s stock price today?
The current price of MNNGF is $0.08. The 52 week high of MNNGF is $0.08 and 52 week low is $0.05.
When is next earnings date of Baijin Life Science Holdings Ltd(MNNGF)?
The next earnings date of Baijin Life Science Holdings Ltd(MNNGF) is .
Does Baijin Life Science Holdings Ltd(MNNGF) pay dividends? If so, how much?
Baijin Life Science Holdings Ltd(MNNGF) does not pay dividend.
Guru Commentaries on OTCPK:MNNGF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Baijin Life Science Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers